Prognostic Utility of Total (68)Ga-DOTATATE-Avid Tumor Volume in Patients with Neuroendocrine Tumors.

Authors

Amit Tirosh
Georgios Z Papadakis
Corina Millo
Dima Hammoud
Samira M Sadowski
Peter Herscovitch
Karel Pacak
Stephen J Marx
Lily Yang
Pavel Nockel
Jasmine Shell
Patience Green
Xavier M Keutgen
Dhaval Patel
Naris Nilubol
Electron Kebebew, George Washington University

Document Type

Journal Article

Publication Date

11-16-2017

Journal

Gastroenterology

DOI

10.1053/j.gastro.2017.11.008

APA Citation

Tirosh, A., Papadakis, G., Millo, C., Hammoud, D., Sadowski, S., Herscovitch, P., Pacak, K., Marx, S., Yang, L., Nockel, P., Shell, J., Green, P., Keutgen, X., Patel, D., Nilubol, N., & Kebebew, E. (2017). Prognostic Utility of Total (68)Ga-DOTATATE-Avid Tumor Volume in Patients with Neuroendocrine Tumors.. Gastroenterology, (). http://dx.doi.org/10.1053/j.gastro.2017.11.008

Peer Reviewed

1